BONE AND BONE MARROW INTERACTION
骨和骨髓的相互作用
基本信息
- 批准号:2082054
- 负责人:
- 金额:$ 16.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1984
- 资助国家:美国
- 起止时间:1984-06-15 至 1997-07-31
- 项目状态:已结题
- 来源:
- 关键词:antiserum bioassay bone marrow breast neoplasms cell bank /registry cell population study chromatography clone cells colony stimulating factor cytokine disease /disorder model granulocyte hematopoietic tissue histochemistry /cytochemistry hypercalcemia interleukin 3 laboratory mouse leukocyte activation /transformation leukocytosis leukopoiesis leukopoietic factor messenger RNA molecular oncology newborn animals oncoproteins osteoclasts osteopetrosis physiologic bone resorption radiotracer transforming growth factors
项目摘要
The long term objective of this research proposal is to increase
our knowledge in physiological interrelationships between
hemopoietic tissue and bone tissue, seeking a possible role of
hemopoietic cells in regulation of bone turnover. Using an animal
del of tumor-induced granulocytosis associated with hypercalcemia,
and isolating the more derived humoral factors, the mechanisms of
bone resorption in hyperplastic bone arrow will be explored.
During the next grant period, the investigation of bone cell
stimulating and bone resorbing humoral agents demonstrated from the
CE mammary carcinoma cell clones will be investigated for their
molecular relationships to granulopoieticc growth factors also
elaborated from the tumor, by the use of molecular probes, well as
specific antisera of hemopoietic growth factors, conventional
biochemical purification procedures and analysis of gene
expression. A new method to precisely analyses osteoclast
progenitors from the bone marrow in vitro will be established,
characterized and utilized for assays of bone resorbing activities.
The in vivo function of isolated CE tumor derived bone modulating
or granulopoietic factor will be tested in vivo for its ability to
care osteopetrosis in mice. The role of the CE mammary carcinoma-
derived factor as well as various purified hemopoietic growth
factors in bone resorbing process will be explored by in vitro
culture experiments using isolated bone forming cells, marrow
stromal cells, marrow mononuclear cells and bone particles and the
mechanism of growth factor mediated bone resorotion will be
dissected. These studies are to disclose many unanswered basic
questions about the defect of hemopoietic growth factors on
physiology of bone marrow and bone turnover; well as to understand
pathophysiology of unexplained hypercalcemia associated with
certain tumors.
这项研究计划的长期目标是增加
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(3)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MINAKO Y LEE其他文献
MINAKO Y LEE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MINAKO Y LEE', 18)}}的其他基金
TUMOR DERIVED MEDIATORS IN BONE MARROW CELL GROWTH
骨髓细胞生长中的肿瘤衍生介质
- 批准号:
3182202 - 财政年份:1985
- 资助金额:
$ 16.48万 - 项目类别:
TUMOR DERIVED MEDIATORS IN BONE MARROW CELL GROWTH
骨髓细胞生长中的肿瘤衍生介质
- 批准号:
3182201 - 财政年份:1985
- 资助金额:
$ 16.48万 - 项目类别:
TUMOR DERIVED MEDIATORS IN BONE MARROW CELL GROWTH
骨髓细胞生长中的肿瘤衍生介质
- 批准号:
3182199 - 财政年份:1985
- 资助金额:
$ 16.48万 - 项目类别:
相似国自然基金
ITS-HPLC-HRMS-Bioassay多级筛选策略指导下海洋真菌中新型抗菌活性产物的发现
- 批准号:41606166
- 批准年份:2016
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of advanced bioassay analysis system for internal dose assessment
开发用于内部剂量评估的先进生物测定分析系统
- 批准号:
23H03142 - 财政年份:2023
- 资助金额:
$ 16.48万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
This service is for The BPN Biologics program requires bioassay development expertise in order to support active cooperative agreements for drug development and discovery.
该服务适用于 BPN Biologics 计划需要生物测定开发专业知识,以支持药物开发和发现的积极合作协议。
- 批准号:
10949343 - 财政年份:2023
- 资助金额:
$ 16.48万 - 项目类别:
Development of a three-dimensional microkidney model and its disease model for bioassay
用于生物测定的三维微肾脏模型及其疾病模型的开发
- 批准号:
23H01983 - 财政年份:2023
- 资助金额:
$ 16.48万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a qualified pharmacokinetic bioassay to support preclinical and clinical studies of MM-008, a non-hormonal contraceptive antibody
开发合格的药代动力学生物测定法以支持非激素避孕抗体 MM-008 的临床前和临床研究
- 批准号:
10459074 - 财政年份:2022
- 资助金额:
$ 16.48万 - 项目类别:
Development of rapid and sensitive bioassay methods to contribute to actinide internal exposure medical response
开发快速、灵敏的生物测定方法,有助于锕系元素内照射医疗反应
- 批准号:
22K12384 - 财政年份:2022
- 资助金额:
$ 16.48万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of simple bioassay for detection of environmental trace contaminants and demonstration in Asian countries
开发用于检测环境痕量污染物的简单生物测定法并在亚洲国家进行示范
- 批准号:
21H01577 - 财政年份:2021
- 资助金额:
$ 16.48万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
L2M Market Assessment Grant: a bioassay to predict birth timing.
L2M 市场评估补助金:预测出生时间的生物测定。
- 批准号:
571251-2022 - 财政年份:2021
- 资助金额:
$ 16.48万 - 项目类别:
Idea to Innovation














{{item.name}}会员




